Cannabis research has caught the attention of medical providers and patients for its many potential health benefits. For decades cannabis has been categorized as a Schedule 1 drug, which is defined as a drug with no currently accepted medical use and a high potential for abuse. And while 33 states have approved its medical use, it continues to be federally prohibited. Cannabis contains more than 100 active compounds that react with cannabinoid receptors in our nervous systems. In spite of prohibitive policies, medical researchers around the world have managed to conduct studies. Research reveals a growing body of evidence of the therapeutic potentials. From tempering chronic pain to reducing anxiety, cannabis holds potential for use. Today we speak with, Dr. Ethan Russo, a neurologist and psychopharmacology researcher. Dr. Russo has spent decades researching exactly how cannabis impacts the human body covering well-known compounds such as THC or CDB, as well as other powerful compounds, like CBG and CBA. Dr. Weil discusses the complicated history of cannabis in U.S culture and suggests explanations for why it has not widely been accepted as medicine. Dr. Russo addresses the concern over long term cognition problems. Dr. Maizes raises the important question, is it possible to achieve the health benefits of cannabis and not experience the psychoactive effects or “high”. With legal access to cannabis on the rise, we discuss the future medical applications of this substance.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related